Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Addition of erythromycin is not currently justified
| The first 150 words of the full text of this article appear below. |
EDITOR
I agree with Wort and Rogers that current British guidelines on
community acquired pneumonia need revision, but I do not believe that
the addition of erythromycin should always be considered in elderly
people.1
They cite, as the basis for this recommendation, a study from Israel in
which serological evidence of Chlamydia pneumoniae was
found in 26% of cases of community acquired pneumonia in elderly people.2 It is not clear, in this or other similar
studies, whether serological detection of C pneumoniae
indicates the cause of the pneumonia or whether treatment directed
against it will make a clinical difference. More than one pathogen was
identified in 30.4% (age 65-74) and 37.8% (age
75) of cases, but
further details are not given. In the original publication other
pathogens were also identified in the majority (69%) of cases in which
C pneumoniae was found (Streptococcus
pneumoniae in 55%).3
A high
Read all Rapid Responses